ADVISORY/ Enterix Inc. to Attend 13th Annual CIBC World Markets Health Care Conference.Business Editors & Health/Medical Writers ADVISORY...for Monday Monday: see week. - Wednesday Wednesday: see week. (November November: see month. 4 - 6) --(BUSINESS WIRE) Enterix, a leading provider of colon cancer colon cancer, cancer of any part of the colon (often called the large intestine). Colon cancer is the second most common cancer diagnosed in the United States. screening technology, invited to renowned health care conference attended by elite members of the investment community
WHAT: The 2002 Canadian Imperial Bank of Commerce (CIBC) World
Markets Health Care Conference provides a forum for
approximately 200 public and private pharmaceutical,
biotechnology, medical device and health service companies to
communicate directly with the investment community. The
conference will be attended by more than 1,000 health care
executives and investors.
WHY: Enterix will be exhibiting at the conference and will be
available to present its business model and strategy
supporting the national availability of !nSure, the first
annual colorectal cancer screening test that is simple,
accurate, inexpensive and non-invasive. Colorectal cancer,
commonly known as colon cancer, is the second leading cause
of cancer deaths in the U.S., behind lung cancer. According
to the American Cancer Society, this year an estimated
150,000 cases will be diagnosed and more than 55,000 people
in the U.S. will die from the disease. If detected early,
colon cancer is highly curable, with a 90 percent five-year
survival rate. However, due to a lack of routine screening,
fewer than 40 percent of colon cancer cases are found at an
early stage, which has resulted in the need for more
efficient routine screening procedures for colon cancer.
!nSure received FDA approval in 2001 and continues to work
closely with medical researchers, practitioners and
insurance providers to create awareness regarding the
necessity to provide national access to an effective, annual
colon cancer screening test.
WHEN: November 4-6, 2002
WHERE: The Plaza Hotel
Manhattan, NY
CONTACT: If you are attending CIBC World Markets Health Care
Conference and would like to speak with Enterix CEO Craig
Sands to discuss the need for improved colon cancer screening
methods and how !nSure will improve the current standard of
care please contact:
Chris Stamm/Cathy DiRamio
Schwartz Communications
781-684-0770
enterix@schwartz-pr.com
|
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion